Clinical Trial Update: Molecular Determinants Affecting Fluoro-L-thymidine (FLT) Positron Emission Tomography (PET) in Rectal Cancer [Phase 1]

View source ↗

Summary

This clinical trial update describes a Phase 1 study examining molecular determinants that influence Fluoro-L-thymidine (FLT) PET imaging in rectal cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rectal Cancer

Drugs mentioned

• Fluoro-L-thymidine (FLT) PET tracer (fluorothymidine)

Snippet

Sponsor: Vanderbilt-Ingram Cancer Center | Conditions: Rectal Cancer | Phase 1 | Status: COMPLETED